Document is current
Any future updates will be listed below
-
Authors
Casas Deza, Diego
Julián Gomara, Ana Belén
Caudevilla Biota, Eva
Beltrán, Belén
Domènech, Eugeni
Gutiérrez Casbas, Ana
Mañosa, Miriam
Zabana, Yamile
Roc Alfaro, Lourdes
Valverde Romero, Emilio
García González, Elena
Sicilia, Beatriz
Laredo, Viviana
Alcalá Escriche, Maria José
Madero Velázquez, Lucia
Ferreiro-Iglesias, Rocío
Palmero Pérez, Antonia
Calafat, Margalida
Rubio Iturria, Saioa
Moraleja Yudego, Irene
Ber Nieto, Yolanda
García Mateo, Sandra
Gisbert, Javier P.
Vicente Lidón, Raquel
Arias, Lara
Alfambra, Erika
Doñate Borao, Ana Belén
Peña González, Elena
Corsino Roche, Pilar
Vicuña Arregui, Miren
Elorza, Ainara
Domínguez Cajal, Manuel
Chaparro, María
Barreiro-de Acosta, Manuel
García-López, Santiago
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)
Journal Title: Gastroenterología y Hepatología (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2024.04.015
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2023.12.012
Content Type: article
Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
